Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review Yoshitaka NishikawaNobuaki HoshinoTakeo Nakayama Invited Review Article 24 May 2020 Pages: 1441 - 1449
Progress on treatment of MET signaling pathway in non-small cell lung cancer Xiaoqing YuSizhe YuYun Fan Review Article 21 May 2020 Pages: 1450 - 1458
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis Keiichiro MoriNoriyoshi MiuraShahrokh F. Shariat Review Article Open access 26 May 2020 Pages: 1459 - 1474
Survival outcomes following craniotomy for intracranial metastases from an unknown primary Melissa GoughMolly NielsenDamian Holliman Original Article Open access 01 May 2020 Pages: 1475 - 1482
Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study Xiaoke ZhuYu HengLei Tao Original Article 27 May 2020 Pages: 1483 - 1491
Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study Xueli NanChao XieJie Liu Original Article 24 May 2020 Pages: 1492 - 1498
Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer Liuwei TangYojiro IshikawaKeiichi Jingu Original Article 30 April 2020 Pages: 1499 - 1505
Prognostic significance of preoperative plasma fibrinogen levels in primary gastrointestinal stromal tumours: a retrospective cohort study Shibo SongXianglong CaoGang Xiao Original Article 23 June 2020 Pages: 1506 - 1514
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study) Masahito KotakaShigeyoshi IwamotoNaohiro Tomita Original Article 14 May 2020 Pages: 1515 - 1522
Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy Takeshi YamadaAkihisa MatsudaHiroshi Yoshida Original Article 11 May 2020 Pages: 1523 - 1532
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data Nobuyuki HinataJunji YoneseHirotsugu Uemura Original Article Open access 09 June 2020 Pages: 1533 - 1542
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes Kazuyuki NumakuraMizuki KobayashiTomonori Habuchi Original Article 11 May 2020 Pages: 1543 - 1550
Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma Ho Won KangSung Pil SeoThe KORCC (KOrean Renal Cell Carcinoma) Group Original Article 05 June 2020 Pages: 1551 - 1561